Contact: +91-9711224068
  • Printed Journal
  • Indexed Journal
  • Refereed Journal
  • Peer Reviewed Journal
International Journal of Urology Research

Vol. 1, Issue 1, Part A (2019)

Yoga intervention for permanent healing of benign prostatic hyperplasia


Alok Thakur


Introduction: Clinical benign prostatic hyperplasia is one of the most common and default disease of aging males. Worldwide prevalence of BPH including USA, UK, Japan and Ghana, varies from 20 – 62% in men over 50 years. It is known to co-exist with prostate cancer at advance age of above 60 years or so. Most commonly medications in practice like Alpha blockers, Phoshodiesterace-5 (PDE5) inhibitors, and 5-alpa-reductase inhibitors can help to control the growth of the prostate and reduce the symptoms of BPH. Sometimes combination of two or more different types of medication is used for relief with burden of host of side effect diseases ranging from low blood pressure to increased risk of diabetes and prostate cancer. Sometime radical surgeries at a later stage become essential. Methods: On clinical detection at the asymptomatic stage as also at the symptomatic stage, the subjects were advised innovative pelvic floor Yogic maneuvers supplementing ongoing medication. Results: Effect of Yogic maneuvers on regression of benign prostate hyperplasia is very encouraging. At the asymptomatic stage benign prostate hyperplasia has been found to respond rapidly to these maneuvers and getting healed almost permanently. Discussion: It is believed that these maneuvers help reducing quantum of blood circulation in prostate lobes that help in regression. Besides regression of BPH, it has been found to provide several other health benefits resulting from improved metabolism of various organs in pelvic and abdomen region and help correcting pelvic floor dysfunction for males as well as females.

Pages: 08-10  |  1743 Views  789 Downloads

International Journal of Urology Research
How to cite this article:
Alok Thakur. Yoga intervention for permanent healing of benign prostatic hyperplasia. Int. J. Urol. Res. 2019;1(1):08-10. DOI: 10.33545/26646617.2019.v1.i1a.3